Proteomic analysis of possible target-related proteins of cyclophosphamide in mice thymus

Food and Chemical Toxicology

Volumn 47, Issue 8, 2009, Pages 1841-1847

  Ma, Chao ^a   Yue, Qing Xi ^a   Guan, Shu Hong ^a   Wu, Wan Ying ^a   Yang, Min ^a   Jiang, Bao Hong ^a   Liu, Xuan ^a   Guo, De An ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Cyclophosphamide; Ganoderma lucidum; Immuno suppression; Polysaccharides; Proteomics; Thymus

Indexed keywords

CYCLOPHOSPHAMIDE; GANODERMA LUCIDUM EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; GANODERMA LUCIDUM; IMMUNE DEFICIENCY; INTERMETHOD COMPARISON; MALE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; PROTEOMICS; THYMUS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BLOTTING, WESTERN; BODY WEIGHT; CELL PROLIFERATION; CYCLOPHOSPHAMIDE; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPHOCYTES; MALE; MICE; ORGAN SIZE; PROTEINS; PROTEOMICS; SILVER STAINING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; THYMUS GLAND;

GANODERMA LUCIDUM; MUS;

EID: 68649126517     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.04.041     Document Type: Article

References (28)

1. Bischoff P.L., Holl V., Coelho D., Dufour P., Weltin D., and Luu B. Apoptosis at the interface of immunosuppressive and anticancer activities: the examples of two classes of chemical inducers, oxysterols and alkylating agents. Current Medicinal Chemistry 7 (2000) 693-713
2. Castro-Caldas M. Annexin-1: 2nd messenger of the anti-inflammatory actions of glucocorticoids. Acta Reumatologica Portuguesa 31 (2006) 293-302
3. D'Acquisto F., Paschalidis N., Sampaio A.L., Merghani A., Flower R.J., and Perretti M. Impaired T cell activation and increased Th2 lineage commitment in Annexin-1-deficient T cells. European Journal of Immunology 37 (2007) 3131-3142
4. D'Acquisto F., Paschalidis N., Raza K., Buckley C.D., Flower R.J., and Perretti M. Glucocorticoid treatment inhibits annexin-1 expression in rheumatoid arthritis Cd4+ T cells. Rheumatology 47 (2008) 636-639
5. Dumont F., and Barrois R. Effect of treatment with cyclophosphamide on the electrophoretic mobility and mitogen responsiveness of mouse thymus cells. Biomedicine 23 (1975) 391-395
6. Fraiser L.H., Kanekal S., and Kehrer J.P. Cyclophosphamide toxicity. Characterising and avoiding the problem. Drugs 42 (1991) 781-795
7. Hansen R.J., Nagasubramanian R., Delaney S.M., Samson L.D., and Dolan M.E. Role of O6-methylguanine-DNA methyltransferase in protecting from alkylating agent-induced toxicity and mutations in mice. Carcinogenesis 28 (2007) 1111-1116
8. Hemendinger R.A., and Bloom S.E. Selective mitomycin C and cyclophosphamide induction of apoptosis in differentiating B lymphocytes compared to T lymphocytes in vivo. Immunopharmacology 35 (1996) 71-82
9. Hiramine C., Nakagawa T., Miyauchi A., and Hojo K. Thymic nurse cells as the site of thymocyte apoptosis and apoptotic cell clearance in the thymus of cyclophosphamide-treated mice. Laboratory Investigation 75 (1996) 185-201
10. Hirst J., King M.S., and Pryde K.R. The production of reactive oxygen species by complex I. Biochemical Society Transactions 36 (2008) 976-980
11. Kaufmann S.H.E., Hahn H., and Diamantstein T. Relative susceptibilities of T cell subsets involved in delayed-type hypersensitivity to sheep red blood cells to the in vitro action of 4-hydroperoxycyclophosphamide. Journal of Immunology 125 (1980) 1104
12. Loc N.K., Olah I., Takacs L., Kittner Z., and Toro I. Effect of cyclophosphamide on the rat thymus. Acta Morphologica Academiae Scientiarum Hungaricae 29 (1981) 319-333
13. Ma C., Guan S.H., Yang M., Liu X., and Guo D.A. Differential protein expression in mouse splenic mononuclear cells treated with polysaccharides from spores of Ganoderma lucidum. Phytomedicine 15 (2008) 268-276
14. Mitchell I., and Deshpande N. Drug effects on certain enzymes of carbohydrate metabolism in MCF-7 cells in culture. Clinical Oncology 10 (1984) 253-260
15. Murata M., Suzuki T., Midorikawa K., Oikawa S., and Kawanishi S. Oxidative DNA damage induced by a hydroperoxide derivative of cyclophosphamide. Free Radical Biology and Medicine 37 (2004) 793-802
16. Ogiso T., Noda N., Asai N., and Kato Y. Antitumor agents. I. Effect of 5-fluorouracil and cyclophosphamide on liver microsomes and thymus of rat. Japanese Journal of Pharmacology 26 (1976) 445-453
17. Pang X., chen Z., Gao X., Liu W., Slavin M., Yao W., and Yu L.L. Potential of a novel polysaccharide preparation (GLPP) from Anhui-grown Ganoderma lucidum in tumor treatment and immunostimulation. Journal of Food Science 72 (2007) S435-S442
18. Patterson R.M., and Germolec D.R. Gene expression alterations in immune system pathways following exposure to immunosuppressive chemicals. Annals of the New York Academy of Sciences 1076 (2006) 718-727
19. Rizzardini M., Ferraroli A., Dal Fiume D., and Cantoni L. Cyclophosphamide-impaired regulation of hepatic heme metabolism. Experientia 40 (1984) 1390-1392
20. Sliva D. Cellular and physiological effects of Ganoderma lucidum (Reishi). Mini-Reviews in Medicinal Chemistry 4 (2004) 873-879
21. Sulkowska M., Sulkowski S., Skrzydlewska E., and Farbiszewski R. Cyclophosphamide-induced generation of reactive oxygen species. Comparison with morphological changes in type II alveolar epithelial cells and lung capillaries. Experimental Toxicology Pathology 50 (1998) 209-220
22. Walker V.E., Andrews J.L., Upton P.B., Skopek T.R., deBoer J.G., Walker D.M., Shi X., Sussman H.E., and Gorelick N.J. Detection of cyclophosphamide-induced mutations at the Hprt but not the lacI locus in splenic lymphocytes of exposed mice. Environmental and Molecular Mutagenesis 34 (1999) 167-181
23. Yakovlev G., and Hirst J. Transhydrogenation reactions catalyzed by mitochondrial NADH-Ubiquinone oxidoreductase (complex I). Biochemistry 46 (2007) 14250-14258
24. Yue Q.X., Cao Z.W., Guan S.H., Liu X.H., Tao L., Wu W.Y., Li Y.X., Yang P.Y., Liu X., and Guo D.A. Proteomic characterization of the cytotoxic mechanism of ganoderic acid D and computer automated estimation of the possible drug-target network. Molecular Cellular Proteomics 7 (2008) 949-961
25. Yue Q.X., Xie F.B., Guan S.H., Ma C., Yang M., Jiang B.H., Liu X., and Guo D.A. Interaction of Ganoderma triterpenes with doxorubicin and proteomic characterization of the possible molecular targets of Ganoderma triterpenes. Cancer Science 99 (2008) 1461-1470
26. Zhang J., Ma K., and Wang H. Cyclophosphamide suppresses thioredoxin reductase in bladder tissue and its adaptive response via inductions of thioredoxin reductase and glutathione peroxidase. Chemico-Biological Interactions 162 (2006) 24-30
27. Zhu X.L., Chen A.F., and Lin Z.B. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice. Journal of Ethnopharmacology 111 (2007) 219-226
28. Zickermann V., Drose S., Tocilescu M.A., Zwicker K., Kerscher S., and Brandt U. Challenges in elucidating structure and mechanism of proton pumping NADH:ubiquinone oxidoreductase (complex I). Journal of Bioenergetics and Biomembranes 40 (2008) 475-483